## FCX: Freeport-McMoRan, Inc. - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_20 3.6% below STRENGTH zone (4.0-10.0%); PEG 2.98 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($39.97)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. FCX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Freeport-McMoRan Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!**
- Source: CW33.com | 20251202T120000 | Neutral | Relevance: 99%
- Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Freeport-McMoRan Inc. seeking to recover damages for investors who purchased securities between February 15, 2022, and September 24, 2025. The lawsuit alleges that Freeport-McMoRan made false and misleading statements regarding safety at its Grasberg Block Cave mine in Indonesia, leading to undisclosed risks. Shareholders have until January 12, 2026, to request to be appointed as lead plaintiff in this securities fraud case.

**2. FCX INVESTOR DEADLINE: Freeport McMoRan Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit**
- Source: PR Newswire | 20251201T104500 | Neutral | Relevance: 99%
- Robbins Geller Rudman & Dowd LLP announces a class action lawsuit against Freeport-McMoRan Inc. (NYSE: FCX) for alleged violations of the Securities Exchange Act of 1934. Investors who purchased FCX securities between February 15, 2022, and September 24, 2025, and suffered substantial losses, have until January 12, 2026, to seek appointment as lead plaintiff. The lawsuit claims Freeport-McMoRan failed to disclose inadequate safety measures at its Grasberg Block Cave mine in Indonesia, leading to worker deaths and significant stock declines.

**3. Freeport-McMoRan Inc. (FCX) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before January 12, 2026**
- Source: Fox 59 | 20251201T104400 | Neutral | Relevance: 99%
- Levi & Korsinsky is urging investors in Freeport-McMoRan Inc. (FCX) who suffered losses between February 15, 2022, and September 24, 2025, to contact them regarding a class action securities lawsuit. The lawsuit alleges that Freeport-McMoRan made false statements and concealed inadequate safety measures at its Grasberg Block Cave mine in Indonesia, leading to heightened risks for workers and subsequent regulatory, litigation, and reputational risks. Investors are encouraged to seek information on potential recovery under federal securities laws before January 12, 2026.

**4. FCX Investors Have Opportunity to Lead Freeport-McMoRan Inc. Securities Fraud Lawsuit with the Schall Law Firm**
- Source: GlobeNewswire | 20251202T103000 | Neutral | Relevance: 99%
- The Schall Law Firm is reminding investors of a class action lawsuit against Freeport-McMoRan Inc. (NYSE: FCX) for alleged securities fraud. The lawsuit claims that Freeport made false and misleading statements regarding safety practices at its Grasberg Block Cave mine in Indonesia between February 15, 2022, and September 24, 2025. Investors who suffered losses are encouraged to contact the firm by January 12, 2026, to potentially lead the lawsuit.

**5. SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Freeport-McMoran Inc. (NYSE: FCX)**
- Source: WREG.com | 20251201T084500 | Neutral | Relevance: 99%
- Bernstein Liebhard LLP has announced a securities fraud class action lawsuit against Freeport-McMoran Inc. (NYSE: FCX) on behalf of investors who purchased shares between February 15, 2022, and September 24, 2025. The lawsuit alleges misrepresentations regarding safety at the Grasberg Block Cave mine in Indonesia. Shareholders who lost money are encouraged to join the class action, with a lead plaintiff deadline of January 12, 2026.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | JP Morgan | $58 | $50 | +16% |
| 2025-11-19 | Morgan Stanley | $44 | $46 | -4% |
| 2025-11-19 | BMO Capital | $47 | $48 | -2% |
| 2025-11-19 | Scotiabank | $47 | $51 | -8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | JP Morgan | main | Overweight |
| 2025-11-19 | Morgan Stanley | main | Overweight |
| 2025-11-19 | BMO Capital | main | Outperform |
| 2025-11-19 | Scotiabank | up | Sector Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.05M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.0% (+1.4%)
- Blackrock Inc.: 7.4% (+0.6%)
- Fisher Asset Managem: 4.4% (+1.4%)
- State Street Corpora: 4.3% (+1.1%)
- Capital Research Glo: 2.9% (-31.2%)

### Key Risks

1. Valuation risk: PEG 3.0x with declining EPS estimates leaves no margin for error.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +2.0% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.98 signals overvaluation risk, limited margin of safety. Forward P/E 20.2x attractive for 40% earnings growth. Balance sheet: strong liquidity (2.5x). Analyst sentiment negative (3 target cuts vs 1 raises). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $66.7B |
| Beta | 1.48 |
| 52W Range | $27.66 - $49.12 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.98 |
| Forward P/E | 20.2 |
| Current P/E | 28.3 |
| YoY Growth | 39.9% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from 1.6% to 3.6% (+2.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.4pp (needs >4.0% for momentum thesis). MRS_5 at 0.6% confirms short-term momentum alignment. AM_20 at 5.4% shows strong absolute momentum above own 20MA. Outperforming sector by 3.5pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 59.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.60% (CS: 87) | Neutral |
| RSI_14 | 58.8 | Neutral |
| MACD Histogram | 0.37 | Bullish |
| vs SMA20 | 1.054x | Above |
| vs SMA50 | 1.055x | Above |
| vs SMA200 | 1.063x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $42.97
- **Stop Loss:** $39.97 (7.0% risk)
- **Target:** $45.97 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 333
- **Position Value:** $14,309.01
- **Portfolio %:** 14.31%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-01-22 (Est: $0.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.41 | $0.50 | +22.8% |
| 2025Q2 | $0.44 | $0.54 | +21.8% |
| 2025Q1 | $0.23 | $0.24 | +4.6% |
| 2024Q4 | $0.22 | $0.31 | +43.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*